True or False for Stem Cell Awareness Day 2018 is an excellent and needed RegMedNet feature. There are many misconceptions about stem cells in the research space, and even more misinformation or lacking information in the stem cell industrial space. These sometimes surprising deficits in knowledge and understanding inhibit progress in stem cell medicine and stem cell commercial
What is cryopreservation? Preserving by freezing, usually at extremely low temperatures (e.g., ≤ 130^oC). What is cryopreservation of cells? Freezing cells in a manner in which they remain viable after thawing. What is a blood spinning machine used for? To separate the cellular components of unclotted blood (red blood cells and white blood cells) from
Asymmetrex’s Adult Tissue Stem Cell Biomarker Technology Enables Cancer Stem Cell Research Cancer stem cells are cells found in tumors that have the ability to propagate the tumor after its dissociation. In some tumors, this property is expressed by a large fraction of the total tumor cells, meaning abundant cancer stem cells. However, in many
Asymmetrex’s SACK Technology Makes Adult Tissue Stem Cell Genetic Engineering a Simple Reality By providing highly enriched populations of tissue-specific adult stem cells, Asymmetrex’s SACK technology makes direct adult tissue stem cell engineering practical for the first time. With SACK agent supplementation, cultures of SACK strains have stem cell fractions that range from 20% to
In Achieving the Technology for the Identification of Adult Stem Cells, and the Ability to Count Adult Tissue Stem Cells, Asymmetrex Will Change the Nature of Tissue Stem Cell Research and Biomedicine On April 29, 2015, Asymmetrex launched a one-year crowdsourcing campaign to engage the global tissue stem cell research community in the evaluation of Asymmetrex’s newest
Regenerative Medicine is Awaiting the Mass Production of Therapeutic Adult Tissue Stem Cells that is Possible with Asymmetrex’s SACK Technology and Use of Mouse | Rat | Human Tissue Cells I. SACK Manufacturing of Human Adult Tissue Stem Cells Asymmetrex has a vision of developing SACK manufacturing-scale processes for mass production of human tissue stem
Through the Development of a Universal Technology for Adult Stem Cell Production, Asymmetrex will Accelerate Regenerative Medicine. Background for the “Suppression of Asymmetric Cell Kinetics (SACK)” Technology Asymmetrex’s solution to the adult tissue stem cell production problem is based on a seminal insight by its founder. In a 2001 research report, Dr. Sherley and his
Asymmetrex’s AlphaSTEM Technology Is A First-Ever Technology For Quantitative Analysis Of Adult Tissue Stem Cells That Will Accelerate Progress In Stem Cell Biomedicine Click here to download a slide deck with the most recent technological benchmarks. Posted October 27, 2015 Overview Asymmetrex, LLC and AlphaSTAR Corporation (ASC) have partnered to develop a first-of-its-kind computer simulation-primary cell culture
Now that Massachusetts stem cell biotechnology company Asymmetrex has developed the first and only technology for specific and accurate counting of therapeutic tissue stem cells, today the company has launched a campaign to alert stem cell scientists, physicians, and patients to the long unmet need of a means to count tissue stem cells. The major
No matter what the specific discipline, the best scientific research strives to be quantitative. Throughout research and practice in science, engineering, and medicine, measuring the focus of investigation is an implicit essential principle. In cell biology, this crucial application is cell counting. How are cell counts calculated? In all cell counting methods, three general steps